Electroencephalographic Microstates During Sleep and Wake in Schizophrenia
Murphy, Michael. 2024. “Electroencephalographic Microstates During Sleep and Wake in Schizophrenia.”
Search
Search results
724 results found
Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders
Shepard, Nate. 2024. “Differential Functional Consequences of GRIN2A Mutations Associated With Schizophrenia and Neurodevelopmental Disorders”. Scientific Reports.
Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data
Nwizu, Chibuikem, Madeline Hughes, Michelle L. Ramseier, Andrew W. Navia, Alex K. Shalek, Nicolo Fusi, Srivatsan Raghavan, Peter S. Winter, Ava P. Amini, and Lorin Crawford. 2024. “Scalable Nonparametric Clustering With Unified Marker Gene Selection for Single-Cell RNA-Seq Data”. BioRxiv.
Assessing the limits of zero-shot foundation models in single-cell biology
Kedzierska, Kasia Z., Lorin Crawford, Ava P. Amini, and Alex X. Lu. 2023. “Assessing the Limits of Zero-Shot Foundation Models in Single-Cell Biology”. BioRxiv.
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Raghavan, Srivatsan, Peter S. Winter, Andrew W. Navia, Hannah L. Williams, Alan DelAdel, Kristen E. Lowder, Jennyfer Galvez-Reyes, et al. 2021. “Microenvironment Drives Cell State, Plasticity, and Drug Response in Pancreatic Cancer”. Cell.
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome
Ebert, B. L., N. Galili, P. Tamayo, J. Bosco, R. Mak, J. Pretz, S. Tanguturi, et al. 2008. “An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome”. PLoS Med 5: e35.
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 662-68.
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Author Correction: Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 748-49.
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., D. S. Neuberg, J. Staunton, M. L. Loh, C. Huard, S. C. Raimondi, F. G. Behm, et al. 2002. “Gene Expression Signatures Define Novel Oncogenic Pathways in T Cell Acute Lymphoblastic Leukemia”. Cancer Cell 1: 75-87.
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
Fuchs, B. C., Y. Hoshida, T. Fujii, L. Wei, S. Yamada, G. Y. Lauwers, C. M. McGinn, et al. 2014. “Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma”. Hepatology 59: 1577-90.